Jann, M., Tanner, J., Ernst, M. - L., Albrecht, P., Hämmig, R., Seidenberg, A., et al. (1990). Drogalkohol Nr. 3/90 : Perspektiven einer neuen Drogenpolitik (Vol. 14). Lausanne: ISPA-Press.
Keywords: government and politics; Switzerland
|
Fehr, W., Groppler, A., Grünbichler, B., Heinz, D., Pfeiffer, W., Teske, A., et al. (2008). Leben im Netz : Phänomen Computerspielsucht (Vol. 14). München: Landesarbeitsstelle Bayern, Aktion Jugendschutz (AJ).
Keywords: addiction; nonchemical addiction
|
various. (2008). Drugnet Europe No. 63 : EMCDDA publishes cannabis reader : Guidelines for estimating the incidence of problem drug use : New EMCDDA report on drug-related public expenditure : Feature: world drug report 2008 – an overview of the global drug situation : Second civil society forum on drugs in the EU : Cross-country collaboration in scientific publishing : New EMCDDA products and services : Management Board approves panel of scientific experts. Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 13(63; 07/2008), 8.
Keywords: international area; Europe; newsletter
|
various. (2008). Drugnet Europe No. 64 : EMCDDA releases Annual report 2008 : Europe's divided stimulant market : Drugs and vulnerable groups of young people : Feature: national drug-related research in Europe : Towards a new EU drugs action plan (2009-12) : Country overviews: national drug situations at a glance : New EMCDDA products and services : Annual report 2008 (continued). Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 13(64; 10/2008), 8.
Keywords: international area; Europe; newsletter
|
various. (2008). Drugnet Europe No. 62 : Drug problems have no age limits : Estimating the total burden of drug-related mortality : EMCDDA launches best practice portal : Feature: monitoring drug-facilitated sexual assault : BZP to be placed under control across the EU : EMCDDA conference: 15 years of monitoring : New EMCDDA products and services : Scientific Committee: new Chair and Vice-chair. Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 13(62; 04/2008), 8.
Keywords: international area; Europe; newsletter
|
various. (2008). Drugnet Europe No. 61 : EMCDDA performing well : New E-POD case study on GHB and GBL : Standardising the monitoring of drugrelated public expenditure : Feature: UNGASS review gets under way : EMCDDA and ESPAD agree cooperation framework : Technical assistance project with the Western Balkans kicks off : New EMCDDA products and services : Management Board adopts 2008 budget. Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 13(61; 01/2008), 8.
Keywords: international area; Europe; newsletter
|
Pfäffli, M., Oswald, F., & Weinmann, W. (2013). Urinschnelltests (Immunoassays) auf Drogen und Medikamente : Wissenswertes für den Arzt. Schweizerisches Medizin-Forum = Forum médical suisse = Swiss medical forum, 13(16; 04/2013), 318–322.
Abstract: - Urinschnelltests sind ein häufig genutztes, einfaches und kostengünstiges Verfahren zur Dokumentation einer (Nicht-)Einnahme von Drogen und Medikamenten. – Urinschnelltests können bei einer Reihe häufig verwendeter Medikamentenwirkstoffe falsch-positive Reaktionen zeigen. – Die Resultate von Urinschnelltests haben aufgrund der möglichen Kreuzreaktionen lediglich hinweisenden, jedoch nicht beweisenden Charakter. – Vom Betroffenen bestrittene positive Resultate müssen mittels einer Bestätigungsanalyse überprüft werden. – Eine passive Cannabisexposition als Ursache eines positiven Cannabis-Urinschnelltests ist im Allgemeinen als Schutzbehauptung anzusehen. – Opiatkonsum, Codeineinnahme und Genuss von Mohnsamen (Mohnkuchen etc.) können nicht mittels (nicht-apparativen) Schnelltests unterschieden werden.
Keywords: screening and diagnostic method for AOD use; urinalysis; physician; illicit drug; cannabis; opioids in any form; codeine; recommendations or guidelines
|
Pfäffli, M., Oswald, F., & Weinmann, W. (2013). Recherche de drogues et de médicaments par tests rapides d'urine (immuno-essais) : informations utiles pour les médecins. Schweizerisches Medizin-Forum = Forum médical suisse = Swiss medical forum, 13(16; 04/2013), 318–322.
Abstract: - L’analyse d’urine rapide est un procédé fréquemment utilisé, simple et économique afin de documenter une prise (ou non) de drogues et de médicaments. – Pour de nombreux principes actifs couramment utilisés, l’analyse d’urine rapide peut présenter une réaction faussement positive. – En raison des réactions croisées potentielles, le résultat d’une analyse d’urine rapide est purement indicatif et n’est en rien probant. – Les résultats positifs contestés doivent être vérifiés grâce à une analyse de confirmation. – Généralement, l’explication d’une analyse d’urine rapide positive par une exposition passive au cannabis doit être considérée comme un argument de défense. – La consommation d’opiacées, de graines de pavot (gâteau aux graines de pavot, etc.) et la prise de codéine
Keywords: screening and diagnostic method for AOD use; urinalysis; physician; illicit drug; cannabis; opioids in any form; codeine; recommendations or guidelines
|
Dole, V. P. (1994). What have we learned from three decades of methadone maintenance treatment? Drug and alcohol review, 13(1), 3–4.
Keywords: treatment and maintenance; methadone maintenance; history; international area; drug substitution therapy
|
Darke, S. (1994). The Use of Benzodiazepines Among Injecting Drug Users. Drug and alcohol review, 13, 63–69.
Abstract: Benzodiazepine use among injecting drug users (IDUs) presents a major clinical and public health problem that may increase in importance. The current paper examines the research on the extent of benzodiazepine use among IDUs and the harmful consequences associated with such use. Numerous studies have found benzodiazepine use to be widespread among IDUs, and to be associated with greater levels of risk-taking and polydrug use, and poorer psychosocial functioning than other IDUs. The injection of benzodiazepines has also been reported, and presents problems in itself. The implications of existing research for both clinical practice and research are discussed.
Keywords: addiction; AOD dependence; chemical addiction; benzodiazepines
|
